1. Abbott, M. F. and G. Dukes (2009) Global Pharmaceutical Policy (London and New York: Edward Elgar).
2. Almeida, E. N. D. (2009) ‘Analise do trabalho de qualificação de fornecedores de insumos farmacêuticos na unidade de Farmanguinhos’, Masters Thesis in Public Health, FIOCRUZ, Rio de Janeiro, Brazil.
3. Amann, E. (2000) Economic Liberalisation and Industrial Performance in Brazil (New York: Oxford University Press).
4. Amin, T. (2010) ‘Re-visiting the Patents and Access to Medicines Dichotomy: An Evaluation of TRIPs Implementation and Public Health Safeguards in Developing Countries’. In Yu, O. Aginam and J. Harrington (eds) Global Governance of HIV/AIDS: Intellectual Property and Access to Essential Medicines (London: Edward Elgar).
5. ANVISA, (2009) ‘Medicamentos Genéricos.’ July,
http://portal.anvisa.gov.br/wps/ content/Anvisa + Portal/Anvisa/Inicio/Medicamentos/Assunto + de + Interesse/Medicamentos + genericos
/wps/%20content/Anvisa%E2%80%89+%E2%80%89Portal/Anvisa/Inicio/Medicamentos/Assunto%E2%80%89+%E2%80%89de%E2%80%89+%E2%80%89Interesse/Medicamentos%E2%80%89+%E2%80%89genericos, accessed September 2012.